The defense industry has reached a historic inflection point. As of January 8, 2026, the landscape for aerospace and defense contractors has been permanently reshaped by the unveiling of a staggering $1.5 trillion U.S. defense budget proposal. Among the "Big Prime" contractors, few are as uniquely positioned to capitalize on this fiscal surge as Northrop [...]
We spend a lot of time obsessing over quarterly earnings reports, P/E ratios, and market trends when we try to figure out why a stock moves the way it does. But beneath the cold, hard numbers lies a variable that is much harder to quantify yet infinitely more impactful: the people sitting in the C-suite. [...]
Investors looking to buy fast-growing AI companies trading at attractive valuations should take a closer look at these two names before they jump higher.
The number of people applying for jobless benefits for the first time ticked up very modestly from a lower revised number, but remains at very muted levels.
After a historic 2025 rally, silver is swinging wildly. Goldman Sachs says thin London inventories, tariffs and ETF demand could keep volatility elevated.
The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.
